MedTrace Logo

Hepatitis C Virus and the Humoral Immune System

NCT00219999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161

Last updated 2013-08-09

No results posted yet for this study

Summary

The purpose of this study is to measure specific chemokines, antibodies, and antibody-producing B cells in the blood of patients with hepatitis C virus (HCV) infection. Our hypothesis is that changes in chemokine levels affect the development of an effective immune response against HCV.

Conditions

  • Hepatitis C Virus

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • New York Presbyterian Hospital

    collaborator OTHER

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Lynn B Dustin, PHD · Rockefeller University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00219999 on ClinicalTrials.gov